New therapy strategies in lung melanoma and asthmatic diseases
Patients with metastasized melanomas have a poor prognosis and a low survival rate. Current therapies for melanoma-metastasis of the lung include surgery dependent on metastasis migration as well as the application of combined chemotherapies. Latest clinical studies explore therapies with the cytokines interleukin-12 (IL-12) and interferon-gamma (IFN-γ), in contrast to the common strategies. In experiments these cytokines have shown to potently inhibit the development of different tumors, especially of lung melanomas. So far this has not led to any therapy improvement, though.
Further Information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50
Contact
Dr. Klaus Kobek
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A universal framework for spatial biology
SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…
How complex biological processes arise
A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…
Airborne single-photon lidar system achieves high-resolution 3D imaging
Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…
